1. Home
  2. ONEW vs STRO Comparison

ONEW vs STRO Comparison

Compare ONEW & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneWater Marine Inc.

ONEW

OneWater Marine Inc.

HOLD

Current Price

$9.39

Market Cap

165.2M

ML Signal

HOLD

Logo Sutro Biopharma Inc.

STRO

Sutro Biopharma Inc.

HOLD

Current Price

$9.35

Market Cap

181.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ONEW
STRO
Founded
2014
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Auto & Home Supply Stores
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
165.2M
181.4M
IPO Year
2019
2018

Fundamental Metrics

Financial Performance
Metric
ONEW
STRO
Price
$9.39
$9.35
Analyst Decision
Buy
Strong Buy
Analyst Count
6
14
Target Price
$13.33
★ $47.23
AVG Volume (30 Days)
77.3K
★ 271.7K
Earning Date
11-12-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ 2.77
N/A
Revenue
★ $1,872,334,000.00
$38,419,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$2.85
N/A
P/E Ratio
$3.43
★ N/A
Revenue Growth
★ 5.62
N/A
52 Week Low
$8.12
$0.72
52 Week High
$17.35
$43.85

Technical Indicators

Market Signals
Indicator
ONEW
STRO
Relative Strength Index (RSI) 43.17 22.90
Support Level $8.98 N/A
Resistance Level $9.89 $16.99
Average True Range (ATR) 0.53 1.23
MACD 0.07 -0.15
Stochastic Oscillator 52.99 2.70

Price Performance

Historical Comparison
ONEW
STRO

About ONEW OneWater Marine Inc.

OneWater Marine Inc is a recreational marine retailer in the United States. The company operates in two segments: Dealership and Distribution. The Dealership segment is involved in selling new and pre-owned boats. It also arranges financing and insurance products, provides repairs and maintenance services, offers marine-related parts and accessories, and supplies slip and storage accommodations at certain locations. The Distribution segment focuses on the manufacturing, assembly, and distribution of marine-related products. These products are supplied to distributors, box retailers, and online retailers through a network of warehouses and distribution centers. The company generates the majority of its revenue from the Dealership segment.

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Share on Social Networks: